THE INVESTOR

메뉴열기
March 29, 2024

Pharma Research Product invests W30.1b in BIOCND

PUBLISHED : January 23, 2018 - 12:46

UPDATED : January 23, 2018 - 12:46

  • 본문폰트 작게
  • 본문폰트 크게
  • 페이스북
  • sms

[DISCLOSURE] Pharma Research Products (214450) announced on Jan. 23 that it has decided to acquire 48.74 percent stake (1,695,558 shares) in pharmaceutical product company BIOCND at 30.1 billion won (US$28.12 million) “to diversify business and to create synergy.” 

This amounts to 17.45 percent of its equity capital. 

By Hwang You-mee (glamazon@heraldcorp.com)

  • 페이스북
  • sms
최상단으로
COPYRIGHT HERALD CORPORATION. ALL RIGHTS RESERVED.